Definium Therapeutics, Inc. · NASDAQ:DFTX

Karlin Daniel received 200,000 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 14, 2026 · Filed Sep 14, 2026

On Sep 14, 2026, Karlin Daniel (Chief Medical Officer) received 200,000 Definium Therapeutics, Inc. shares as an award, leaving 803,699 shares. Filed Sep 14, 2026 (Form 4).

Awarded
200,000 shares
Holding after
803,699 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common SharesAward200,000803,699Direct

Source

View original at SEC

Related